Menu Search
Equities

Bristol-Myers Squibb Co

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BRM:HAM

Bristol-Myers Squibb Co

Actions
  • Price (EUR)50.80
  • Today's Change0.35 / 0.69%
  • Shares traded100.00
  • 1 Year change-1.76%
  • Beta0.2699
Data delayed at least 15 minutes, as of Feb 18 2026 07:01 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Bristol-Myers Squibb Co had relatively flat revenues (48.30bn to 48.19bn), though the company grew net income from a loss of 8.95bn to a gain of 7.05bn. A reduction in the selling, general and administrative costs as a percentage of sales from 16.55% to 14.83% was a component in the net income growth despite flat revenues.
Gross margin72.63%
Net profit margin14.64%
Operating margin21.51%
Return on assets7.73%
Return on equity40.53%
Return on investment10.43%
More ▼

Cash flow in USDView more

In 2025, Bristol-Myers Squibb Co did not generate a significant amount of cash. However, the company earned 14.16bn from its operations for a Cash Flow Margin of 29.37%. In addition the company used 4.13bn on investing activities and also paid 10.35bn in financing cash flows.
Cash flow per share5.43
Price/Cash flow per share11.11
Book value per share9.18
Tangible book value per share-11.12
More ▼

Balance sheet in USDView more

Bristol-Myers Squibb Co has a Debt to Total Capital ratio of 70.91%, a lower figure than the previous year's 291.42%.
Current ratio1.26
Quick ratio1.14
Total debt/total equity2.44
Total debt/total capital0.7091
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.81%
Div growth rate (5 year)0.66%
Payout ratio (TTM)71.87%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		178.12
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.